Skip to content
hero-bg1a

THE NEW ERA CRO

Bespoke, High Quality Clinical Trial Delivery with a Global Reach
Our ServicesGet In Touch
Hero-2

THE NEW ERA CRO

Bespoke, High Quality Clinical Trial Delivery with a Global Reach
GET IN TOUCH
hero2

THE NEW ERA CRO

Bespoke, High Quality Clinical Trial Delivery with a Global Reach
Our Services
hero3

THE NEW ERA CRO

Bespoke, High Quality Clinical Trial Delivery with a Global Reach
GET IN TOUCH

We are a new era Clinical Research Organisation, born in 2013 but with a vision that is light years ahead.

We do things in a modern, flexible way. We are not your traditional CRO.

Our success is driven by our innovative approach of working with a globe-wide panel of local, dedicated experts in the field of clinical trials.

The teams we’ve curated share decades of industry experience, and we can proudly say we have unrivalled regional expertise to deliver your study.

Discover the Momentum Pharma difference
and why you need a New Era CRO

We are not a faceless, monolithic mega-corp, we believe in the personal approach,
so get in touch and let’s talk.
CONTACT US

We Work With

Biotech Companies

We are always striving to help companies reach their innovation potential. 

We are nimble and focused on accelerating the discovery, development and delivery of personalised medicine.

The BioTech companies we work with have cutting edge technology in gene therapy, CAR-T cell therapy, CRISPR, immuno-oncology, checkpoint inhibitors and intra-tumoral treatment, just to name a few. Their need to deliver fast, but reliable data is our speciality – we break down barriers and pull out all the stops to get things accomplished in the Biotech world.

Biotechs are not afraid to push the frontiers and do things differently and neither is Momentum Pharma.

Read More

Pharmaceutical Companies

We work with major Pharma giants who have a commitment to bring solutions from the petri dish to the patient.

They are focused on discovering and delivering transformational medicines and products in several key therapeutic areas: immunology, oncology, neuroscience, infectious disease and cardiology.

They value embedding Momentum Pharma consultants into their teams, ensuring local expertise, project management and the oversight activities of traditional types of CROs.

Read More

Early Development / Start Ups

There are challenges facing everyone who works in clinical trials, but for early stage companies, navigating these successfully can make or break a pipeline.

From the adoption of technology, to regulatory requirements, vendors and selecting appropriate sites, our experts have you covered.

Our flexibility to provide your start up with agile teams that can be scaled up and scaled down, and incorporate the right team players, will help you avoid the disaster of spiralling costs.

Read More

Traditional CROs

We add a global reach and a local expertise to work with you as trusted partner. Everyone has a role to play in the new era of clinical trials and we embrace and support mutual efforts to get a drug to market and to get treatment options out there.

Read More
2013

Established

1,500+

Global Consultants

51

Sponsors Assisted to Date

140+

Studies Engaged on to Date

40+

Countries Worked in to Date

Our Global Reach

Explore How We Help

Rare and Ultra Rare Disease

Our teams understand that rare disease clinical trials are unique in nature and focus. We work with many clients to address unmet medical needs in patients lacking clear, approved therapies. 

We support our Sponsors with diverse teams addressing rare and debilitating diseases where there is an unmet need and no current approved therapy. We know that patient retention is key, and dedicate ourselves to providing high-performance consultants who become ambassadors of the Sponsor.

Some diseases we study include MPS-I, MPS-II, MPS-VII, GLUT-1DS, XLH, TIO, AL Amyloidosis, Systemic Scleroderma, Cystic Fibrosis, Narcolepsy and Obstructive Sleep Disorder.
Read More

Oncology Projects

Complex and challenging protocols demand high-performance teams who are experts in both Haematological Oncology and Solid Tumour Oncology.

Our global consultants work in major medical institutions around the world, addressing some of the most difficult challenges in healthcare. We focus on life-threatening illnesses with an emphasis on understanding toxicity, dose modifications, adverse event profiles and disease progression.

Our team includes RECIST 1.1 experts, with specialists in Solid Tumour (Skin, Colon, Prostate, Breast) and Haematological (CLL, MCL, Multiple Myeloma) conditions
Read More

Tropical Disease

Global health challenges in logistically difficult territories require consultants with in-depth knowledge of the region and its eccentricities. We give you specialists who we are ideally placed to deliver this sensitive advice.

Our African and South African CRAs have a unique understanding of how to operate within the confines of a challenging environment. We address global health challenges that face resource-limited funding or demanding logistics.

Our consultants based in East Africa (Kenya, Nairobi) and South Africa can navigate third-world infrastructure with the tools and awareness that contribute to innovative solutions, as demonstrated by our anti-malaria project for pregnant women in Tanzania.
Read More

Quality Management Projects

We support and collaborate with our clients’ Clinical Quality Assurance group to ensure regulations are current and relevant, and in turn secure full compliance.

Our Quality Managers provide strategic and tactical development, execution and management of the Clinical Operations Clinical Quality Management Programme within major global pharmaceutical companies.

They oversee development of GDP compliance activities and training curricula, clinical trial quality management plans and processes, Clinical Operations SOPs and other process guidance documents.

Our experts also provide strategic planning, preparation and support for Regulatory Authority GCP sponsor, clinical site and clinical vendor inspections
Read More

Quality Control Specialists

We have GCP Quality Control consultants who are passionate about oncology and rare disease projects, and adept at evaluating the site and monitor’s performance on assignments around the world, from Sydney to Vancouver.

Our GCP Quality Control consultants work on multiple Oncology and Rare Disease projects all over the world. They can adapt to different cultures and provide a bird’s eye view of what is happening on site.

Our Consultants are trained to spot problems, risks and misconduct that clients may not be aware of, evaluating the protocol and then assessing areas where damage control may be needed to avoid problems and expenses.

They also provide mentoring, training, assistance with CAPA and in-depth analysis of on-site trends and CRO performance, making them a real investment in quality and oversight.
Read More

On Site Project Assistance

If you have an important site that is falling behind due to staff turnover or bandwidth, we can provide site support so you can develop a rescue plan that gets you back to where you need to be.

Our specialists can schedule days on site, independent of the CRA, so that time is spent with the appropriate staff to clear up action items, provide instruction and deliver training where needed. They work with the site in a variety of ways, with the goal of clearing a path so the CRA can focus on their role, data cleaning and TMF.

Our site specialist can then work in tandem with the CRA to build a rescue plan, working towards compliance with study metrics, well-reviewed data and a smooth-running study.
Read More

Affiliations

Momentum Pharma maintains high standards of corporate governance and we strive to stay current in understanding trends and the changing environment within the industry as well as international business. To facilitate this goal, we are active members of a number of organisations and industry groups, some of which are:

Chartered Institute of Export and International Trade Logo

Subscribe to our newsletter

Sign up to the Momentum Pharma newsletter “Gaining Momentum” to receive the latest content from Momentum Pharma and highlighted news from the sector.

Alliances

Our model relies on having connections and relationships with the foremost consultants and service providers in the industry.  We don’t rely on hearsay but on the direct experience of working with, or a strong recommendation from our trusted group. Excellence/ proven track record in delivery in the following areas:

Consultants
Pharmacovigilance / Safety
Regulatory Services
Clinical Trial Platforms
Supply Chain Management

What Our Clients Say

“Our company has been working with Momentum since 2015, and we could not be happier with their work product, their bespoke attention to our needs, and to the professionalism and genuine caring attitude both Melissa and Jon Melton demonstrate consistently about our patients and our relationship.

We are a rare and ultra-rare biotech and we absolutely need a partner that understands how important each patient’s data is to our obtaining regulatory approvals. Melissa and Jon have done everything they can to ensure that the CRAs they bring to us have the utmost integrity, skill set, and commitment to quality we desire. I am very impressed with their business model and ability to offer additional qualified personnel in areas beyond clinical monitoring as well. I have been involved in clinical research for over 15 years and in health care for over 28 years, and Momentum is one of the best organizations I have had the pleasure to work with. My recommendation is unconditional, any company would be fortunate to work with them.”
Sr. Director, Clinical ProcurementRare Disease Biotech Company
“It is with much enthusiasm that I am writing to recommend the services of Momentum Pharma for your clinical trial support needs."


I have worked with Momentum over the past several years. They display a quality of work that reflects high professional standards. They have a robust database of experienced clinical research experts specializing in oncology and rare disease trials. I appreciated knowing they did not accept unsolicited CVs from job seekers – each consultant was very carefully vetted. The Clinical Research Associates assigned to my team consistently exceeded performance expectations – very rare in this industry.

I found Momentum stood out from other FSPs due to their high degree of honesty, integrity and work ethic. I am confident Momentum will distinguish itself as an important partner for your clinical needs. I can say with confidence, they are an FSP that delivers.”
Director of Clinical Trial ManagementCancer Biotech Company
“It is with much enthusiasm that I provide a recommendation for services provided my Momentum Pharma. During the past four years we have utilised Momentum for monitoring, co-monitoring and oversight visits both in the United States and in Europe across numerous projects.

We have been very pleased with the quality of service provided by the Momentum team. Their representatives are experienced, maintain strong relationships with sites and stakeholders, and are a pleasure to work with. They are responsive, agile and diligent in their delivery.”
Clinical Operations DirectorCancer Biopharmaceutical Start Up
“We have collaborated with Momentum Pharma since 2017, working on a Melanoma study.

Momentum Pharma has provided high quality, experienced monitoring resources to us for work on this study in France, Sweden and Austria.

Their resources are performing both monitoring and regulatory services for us. Momentum Pharma has demonstrated support to Clinical Research Technology continuously from 2017 to current day (March 2020) and we have found them to be experienced, responsive and helpful.”
Chief Operating OfficerClinical Research Organisation
Previous
Next

Latest News

Momentum Pharma Team IAOCR Accreditation

Momentum Pharma Breaks Ground Becoming First Organization to Receive New Certification Assessing Highest Industry Standards

December 11, 2024

The IAOCR Business Process Quality Certification Assesses International Best Practices as Ratified by Industry Experts London and Maidenhead, United Kingdom, 11 December, 2024 – Momentum Pharma has become the first organization to achieve the new Business Process Quality Certification (BPQC) standard from the International Accrediting Organization for Clinical Research (IAOCR).

Read More 🡪
View All

Any Questions? Get in Touch

Jarmila Yu

Jarmila Yu is an award-winning globally ranked Top100 Chief Marketing Officer, she is a Chartered Marketer and Fellow of both the Institute of Data and Marketing and the Chartered Institute of Marketing. She has over 25 years of experience working with fast paced pioneering IT and professional services companies, ranging from start-ups to blue chips in B2B and B2C.

Jarmila is an entrepreneurial marketing strategist who has a passion for innovation, and a track record for growing and transforming business through efficient, effective, and impactful marketing. Her role as CMO for Momentum Pharma is to ensure the marketing and brand is fit-for-purpose, enabling the company to deliver on its mission to provide the highest calibre of excellence to support its clients in continuing to make medical breakthroughs that improves the quality of life and saves lives. 

Cindy Abbas

Cindy is Momentum Pharma’s Administration Manager and joined the company in May 2016 where she performs many roles for the firm.  These include corresponding with Sponsors and the Consultants on contractual administration, checking and organising the submission of monthly invoices and expenses of the Consultants.  Cindy is the principal controller for the Momentum Pharma Database.

Cindy started her career in 1989 and has a strong Accounting and Finance background. She has worked for Global Financial companies in a number of roles including; Team Leader in the Accounting Department and Account Manager for a large US based client.

Matthew Melton

Matthew is Momentum Pharma’s Chief Information Officer. He created the bespoke Database and other platforms that the firm uses. Matthew has an engineering and IT background with a broad technical base.

Matthew has worked in the medical device field during his time with a UK engineering company where he programmed the Hardware Control and UI Software design for the NT1000 radio-frequency generator for Thermal Lesioning medical equipment within an ISO 9001:1994 ‘Quality Systems Manufacturing Environment’. 

Matthew’s technical skills include electrical and electronic software engineering, systems design and administration.  He holds a MSc in Computing and a BEng in Electronic Engineering from Cardiff University of Wales. 

Kristina Valenkova

Joined Momentum Pharma in September 2022 as the Global Operations Coordinator. Kristina has a degree in Design and Innovation with a strong background in Information Technology.

Building upon her knowledge and experience, Kristina’s role is to facilitate continual development of Momentum’s operations around the world. Working alongside the CEO and COO to implement corporate strategy, assisting with the design, development and implementation of bespoke Momentum systems. Kristina also develops and maintains direct relationships with Momentum’s clients and consultants.

Ellesha Nicholas

Joined Momentum Pharma in February 2023 as the Operations Administrator. Ellesha’s role is focused on the administrative and operational day-to-day activities of Momentum Pharma.

Ellesha graduated from Harper Adams University with a BSc degree in Animal Behaviour and Welfare and has successfully achieved a Gold Duke of Edinburgh Award in 2015.

Jon Melton

Graduated from the University of East Anglia with a BA Honours degree in Business Studies and his professional career began in the Insurance and Reinsurance industry in April 2000.  

In 2013, Jon co-founded Momentum Pharma where he holds the role of Chief Operating Officer (COO).

Jon’s career in (Re)Insurance has been wide-ranging in terms of activity and territory. He supported clients and sourced business globally at each stage of his career within the 3 largest global broking houses (Willis, Marsh and Aon). 

Jon also has an in-depth experience in Leadership, Project Management and global business transactions.

Melissa Melton

CEO of Momentum Pharma, possesses over 20 years of clinical research and development experience.  During this time, she has worked extensively in the field throughout the US, Canada, UK and Europe (Finland, Sweden, Belgium, Spain, France, Italy and Ireland). 

Melissa is a Senior Clinical Trial Consultant which roles include; Clinical Program Manager, Senior CRA, ICH/GCP Quality Assurance Consultant, and CRO Oversight Lead.  She has worked for global pharmaceutical giants such as: Roche and J&J, as well as CROs and multiple progressive, cutting-edge Biotech firms. 

Her experience is deep in a myriad of therapeutic areas including: adult and paediatric oncology, haematology, cardiovascular, central nervous system, rare genetic disease and more.  Melissa has been instrumental in relationship building with key opinion leaders, increasing global program development and risk assessment. 

During her expansive career, she has worked on multiple FDA/EMA block buster drugs including the first in class anti-retro viral for HIV (Fuzeon) and numerous life changing Oncology drugs (Avastin, Herceptin, Xeloda and Imbruvica).  Melissa holds a BA in Psychology from the University of Arizona.  She understands the Sponsor’s needs implicitly, her speciality is strategic plans of action for global development.

Dr Helen Buck

Dr. Helen Buck is Momentum’s Consulting Quality and Risk Assessment Manager. She brings to the team 25 years of clinical trials industry expertise and has developed the company’s Standard Operating Procedures (SOP) library, as well as many study plan templates.

Helen has worked on many aspects of clinical trials since starting her Consulting career in 2003 including medical writing and conduct of clinical programmes to ICH GCP guidelines among other roles. Dr. Helen Buck has a PhD in Neuroscience.